Richter SyndromeSymptoms, Doctors, Treatments, Advances & More
Richter Syndrome Overview
Learn About Richter Syndrome
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Chronic Lymphocytic Leukemia (CLL)
Richard Furman is an Oncologist practicing medicine in New York, New York. Dr. Furman is rated as an Elite provider by MediFind in the treatment of Richter Syndrome. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, Bone Marrow Aspiration, and Lymphadenectomy. Dr. Furman is currently accepting new patients.
University Of Texas MD Anderson Cancer Center
William Wierda is a Hematologist and an Oncologist practicing medicine in Houston, Texas. Dr. Wierda is rated as an Elite provider by MediFind in the treatment of Richter Syndrome. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.
Davide Rossi practices practicing medicine in Bellinzona, Switzerland. Mr. Rossi is rated as an Elite expert by MediFind in the treatment of Richter Syndrome. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Chronic B-Cell Leukemia (CBCL), Tissue Biopsy, and Osteotomy.
Summary: This is a national clinical trial, multicentric (28 centers), non-randomized phase 2 study. Population: Patients with previously untreated Richter's syndrome (RS), defined as the occurrence of an aggressive lymphoma (of diffuse large B-cell lymphoma histology) in a patient with chronic lymphocytic leukemia (CLL). Study treatment: The duration of each cycle is 21 days. Cycle 1: Participants will re...


